Published in TB and Outbreaks Week, October 19th, 2004
These findings, by scientists at St. Jude Children's Research Hospital, appear in Structure.
Based on these new insights into the structure of the enzyme, called DHPS, the St. Jude team has also developed a new molecule that appears likely to be able to block the enzyme's activity without triggering resistance.
DHPS normally combines the molecules DHPP and pABA during part of a biochemical pathway that produces...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.